TickerFactsScreenerDevelopers

ADMA BIOLOGICS, INC. (ADMA) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2010: -$3.93M2011: $385.8K2012: $9.42M2013: $21.57M2014: $6.01M2015: $821.0K2016: -$4.46M2017: $40.33M2018: $19.77M2019: $26.19M2020: $88.25M2021: $141.17M2022: $151.97M2023: $135.21M2024: $349.02M2025: $477.32M$477.32M
2010Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$477.32M+36.8%
2024$349.02M+158.1%
2023$135.21M-11.0%
2022$151.97M+7.7%
2021$141.17M+60.0%
2020$88.25M+236.9%
2019$26.19M+32.5%
2018$19.77M-51.0%
2017$40.33M+1004.9%
2016-$4.46M-642.9%
2015$821.0K-86.3%
2014$6.01M-72.1%
2013$21.57M+128.9%
2012$9.42M+2342.5%
2011$385.8K+109.8%
2010-$3.93M—